Intravenous Thrombolysis and NOAC

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 280 participants.

Also called NCT06749834

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 280 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06749834
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06749834. Randomized; double masking; primary purpose treatment. Start 2025-01-27 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Intravenous Thrombolysis and NOAC
Condition
Acute Ischemic Stroke
Intervention (Drug)
Intravenous thrombolysis
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)

Record details

Record id
cardio:ct-nct06749834
Content hash
5939001f188211544b284b0d56ebc3063ca1853e41eabdcc42b2d64d87400a5d